NYSE:MDHealthcare
Why Pediatrix (MD) Is Down 8.3% After Profitability Rebound And 2026 EBITDA Outlook Update
Pediatrix Medical Group reported past fourth-quarter 2025 sales of US$493.77 million versus US$502.36 million a year earlier, with diluted EPS from continuing operations rising to US$0.40 and full-year 2025 net income improving to US$165.39 million on revenue of US$1.91 billion.
The company’s return to full-year profitability followed a major shift toward core hospital-based neonatology and maternal-fetal services, supported by practice disposals, higher same-unit revenue, and renewed...